Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ahmad Alaskar"'
Autor:
Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives The selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and on
Externí odkaz:
https://doaj.org/article/8f441ec800cb484883e31233e4f0a063
Autor:
Abdullatif Alarfaj, Manar Almaghaslah, Athari Alotaibi, Mohammad Bosaeed, Majed Al-Jeraisy, Yaseen M. Arabi, Hassan Almarhabi, Abderrezak Bouchama, Abdulmajid Al Arfaj, Mohammed Alzahrani, Abdulrahman Alsaedy, Majid Alshamrani, Omar Aldibasi, Malak Alharbi, Hajar Alqahtani, Badriah M. Almutairi, Khalid Ghalilah, Abdullah Bawazir, Nasser Alqahtani, Abdulhakeem O. Althaqafi, Nawaf M. Alyahya, Hawra Albayat, Sameera M. Al Johani, Ahmad Alaskar, Ebrahim Mahmoud, Jumana AlJishi, Faisal M. Alharbi, Hadeel Altayib, Saud AlEisa, Ahmad Alharbi
Publikováno v:
Infectious Diseases and Therapy
Introduction Antiviral drugs have shown limited effectiveness in treating patients with coronavirus disease 2019 (COVID-19). We aimed to assess the effects of a favipiravir and hydroxychloroquine combination on treating moderate-to-severe COVID-19 pa
Autor:
Sabhi Rahman, Al-Shaimaa Al-hallaj, Atef Nedhi, Gmal Gmati, Khadega A. Abuelgasim, Haya Al Jama, Thadeo Trivilegio, Abdullah Mashour, Ahmad Alaskar, Mohamed Boudjelal
Publikováno v:
Journal of Circadian Rhythms, Vol 15, Iss 1 (2017)
Disregulation of genes making up the mammalian circadian clock has been associated with different forms of cancer. This study aimed to address how the circadian clock genes behave over the course of treatment for both the acute and chronic forms of l
Externí odkaz:
https://doaj.org/article/b8968f0847ea4e178b4cc5ef3de7746e
Autor:
Mohammed Bosaeed, Ebrahim Mahmoud, Ahmad Alharbi, Hadeel Altayeib, Hawra Albayat, Faisal Alharbi, Khalid Ghalilah, Abdulmajid Al Arfaj, Jumana AlJishi, Abdullatif Alarfaj, Hajar Alqahtani, Badriah M. Almutairi, Manar Almaghaslah, Nawaf M. Alyahya, Abdullah Bawazir, Saud AlEisa, Abdulrahman Alsaedy, Abderrezak Bouchama, Malak Alharbi, Majid AlShamrani, Sameera Al Johani, Majed Aljeraisy, Mohammed Alzahrani, Abdulhakeem O. Althaqafi, Hassan Almarhabi, Athari Alotaibi, Nasser Alqahtani, Yaseen Arabi, Omar Aldibasi, Ahmad Alaskar
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S261-S262
Introduction: In ALL, current drug efficacy studies focus on reducing leukemia cell burden. However, if drugs have limited effects on LSCs, these cells may expand and eventually cause relapse. The experimental anti-leukemic drug parthenolide (PTL) ac
Autor:
Omar Aldibasi, Sameera Aljohani, Majed Al-Jeraisy, Ahmad Alharbi, Mohammad Hussein, Ahmad Alaskar, Adel Alothman, Ebrahim Mahmoud, Marwan Nashabat, Badriah M. Almutairi, Abdulrahman Alsaedy, Yaseen M. Arabi, Mohammad Bosaeed, Manar Almaghaslah, Hajar Alqahtani, Abderrezak Bouchama
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Objectives The selected combination was based on limited evidence clinically and in vitro on the efficacy of the Favipiravir and Hydroxychloroquine in SARS-CoV-2. The two medications were listed in many guidelines as treatment options and ongoing tri
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S205
Autor:
Mohsen Alzahrani, F. Al‐Amro, Hana Fakhoury, Mohammed AlBalwi, Dunia Jawdat, M. Alarifi, N. Atallah, Ahmad Alaskar, M. Al‐Muallimi, Ali H. Hajeer, A. Alalwan, A. Al‐Turki
Publikováno v:
HLA. 90:292-294
CCR5 is a chemokine receptor that also was found to be used by HIV as a co-receptor for entering target cells. A 32 bp deletion was described in certain people that rendered CCR5 non-functional. The mutant allele CCR5-Δ32 has been shown to prevent H
Autor:
Dunia Jawdat, M. Al Jumah, M. F. El-Muzaini, Bill Kalionis, Ahmad Alaskar, A. Almotery, N. A. Alshehri, Tanvir Khatlani, E. Bahattab, A. M. Al Subayyil, M. H. Abumaree, Fawaz Abomaray
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-15 (2019)
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-15 (2019)
Background Mesenchymal stem cells derived from the chorionic villi of human placentae (pMSCs) produce a unique array of mediators that regulate the essential cellular functions of their target cells. These properties make pMSCs attractive candidates
Autor:
Saeed Alshieban, Rehab Yassin, Ayman Alhejazi, Mohsen Alzahrani, Ahmad Alaskar, Tabreez Pasha, Moussab Damlaj
Publikováno v:
Hematology/oncology and stem cell therapy. 12(3)